Elixirr International (LON:ELIX) Earns “Buy” Rating from Canaccord Genuity Group

Elixirr International (LON:ELIX)‘s stock had its “buy” rating reaffirmed by equities research analysts at Canaccord Genuity Group in a report issued on Monday, MarketBeat reports. They presently have a GBX 1,275 target price on the stock. Canaccord Genuity Group’s target price suggests a potential upside of 161.81% from the company’s current price.

Separately, Berenberg Bank restated a “buy” rating and issued a GBX 1,060 price target on shares of Elixirr International in a report on Monday. Two investment analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average target price of GBX 1,167.50.

Elixirr International Price Performance

Shares of LON:ELIX opened at GBX 487 on Monday. Elixirr International has a 52 week low of GBX 461 and a 52 week high of GBX 905.63. The company has a 50-day moving average price of GBX 627.30 and a 200 day moving average price of GBX 667.34. The company has a market cap of £241.37 million, a P/E ratio of 13.10 and a beta of 0.65. The company has a quick ratio of 1.29, a current ratio of 0.80 and a debt-to-equity ratio of 41.61.

Elixirr International (LON:ELIX) last released its earnings results on Monday, September 21st. The company reported GBX 37.50 earnings per share (EPS) for the quarter. Elixirr International had a return on equity of 14.24% and a net margin of 12.58%. Research analysts predict that Elixirr International will post 44.516129 earnings per share for the current year.

Insiders Place Their Bets

In other news, insider Nick Willott bought 100,000 shares of the business’s stock in a transaction that occurred on Thursday, July 9th. The shares were acquired at an average cost of GBX 43 per share, with a total value of £43,000. 33.22% of the stock is currently owned by corporate insiders.

Elixirr International News Summary

Here are the key news stories impacting Elixirr International this week:

• Positive Sentiment: Strong first-half performance: Revenue rose 25% to £89 million, while AI-related revenue reached £8.1 million. The company also reported higher profit and record earnings for the period ended June 30, 2026. Elixirr H1 Revenue Rises 25% to £89 Million as AI-Related Revenue Reaches £8.1 Million
• Positive Sentiment: Analyst support remains favorable: Canaccord Genuity reaffirmed its “buy” rating with a GBX 1,275 price target, while Berenberg maintained its “buy” recommendation and set a GBX 1,060 target. These targets imply substantial potential upside from recent trading levels. Elixirr International’s Buy Rating Reaffirmed at Canaccord Genuity Group Berenberg Bank Reaffirms Buy Rating for Elixirr International
• Neutral Sentiment: Corporate broker clarification: Elixirr issued an update clarifying its lineup of joint corporate brokers. The announcement appears administrative and does not indicate a change to the company’s operating outlook. Elixirr Clarifies Line-Up of Joint Corporate Brokers
• Negative Sentiment: Guidance disappointed investors: Although Elixirr delivered record profits and healthy sales growth, management’s forward guidance was viewed as insufficiently strong. The resulting concern about future growth and expectations outweighed the positive earnings figures, prompting a decline in the shares. Elixirr International’s Guidance Disappoints Despite Record Profits

About Elixirr International

Elixirr is a global consulting firm with a bold ambition: to become the best consulting firm in the world.

Founded in 2009 to challenge a declining industry standard, we’ve grown from a single vision into a powerhouse of entrepreneurial talent. We partner with businesses around the world to deliver transformational results, from boardroom strategy through to execution, powered by the technology of tomorrow. We do this in a way that’s anything but traditional – helping our clients change the game in their industries, just as we are changing the game in ours.